Skip to main content

Table 2 Quantitative autonomic testing

From: Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

 

HC (n = 50)

M (SD)

ME/CFS (n = 50)

M (SD)

Post-COVID (n = 87)

M (SD)

Statistics

Bonferroni (p)

ME/CFS vs post-COVID

ME/CFS vs HC

Post-COVID vs HC

HF-RRI (ms2)

12,443.3 (3668.1)

399.5 (669.3)

962.5 (2986.3)

H = 7.5*

 

0.019

 

HFnu-RRI (%)

40.9 (16.6)

37.9 (9.7)

37.5 (16.4)

H = 1.5

   

LF-dBP (mmHg2)

32.6 (161.1)

9.8 (16.6)

15.5 (49.4)

H = 9.5**

0.032

0.013

 

LFnu-dBP (%)

43.5 (13.1)

43.9 (14.4)

45.7 (14.3)

H = 2.3

   

LF/HF

1.5 (1.0)

2.4 (3.2)

2.3 (2.6)

H = 3.5

   

SV

82.4 (16.6)

72.2 (18.1)

77.3 (17.3)

H = 10.1**

 

0.005

 

CO

5.3 (1.3)

5.4 (1.5)

5.7 (1.4)

H = 2.9

   

TPR

1400.9 (427.4)

1381.5 (344.0)

1405.4 (465.4)

H = 0.2

   

BRS mean

16.3 (8.6)

12.9 (9.7)

13.0 (7.9)

H = 7.4*

 

0.038

 

Deep breathing index

16.3 (6.9)

16.8 (8.2)

16.8 (8.0)

H = 0.0

   

E/I ratio

1.3 (0.1)

1.2 (0.1)

1.2 (0.1)

H = 1.9

   

Valsalva ratio

1.7 (0.3)

1.6 (0.4)

1.6 (0.3)

H = 0.7

   

Valsalva PRT (s)

2.6 (0.9)

2.8 (1.1)

2.5 (1.0)

H = 1.9

   

ΔsBP phase II

– 4.5 (19.7)

– 11.0 (18.5)

– 11.7 (22.4)

H = 7.5*

  

0.035

ΔdBP phase II

– 33.1 (19.8)

– 33.7 (15.2)

– 33.7 (16.6)

    

ΔsBP phase II late

2.2 (20.3)

– 1.2 (22.2)

– 0.6 (19.8)

    

ΔdBP phase II late

12.8 (15.3)

8.7 (15.1)

12.4 (18.1)

    

ΔsBP phase IV

19.2 (17.4)

19.5 (17.5)

23.6 (18.8)

    

ΔdBP phase IV

10.7 (13.0)

10.5 (9.9)

15.7 (15.4)

    

Hemodynamic responses to Tilt

       

Supine

       

sBP

112.7 (21.0)

112.6 (18.)

112.6 (13.5)

H = 0.9

   

dBP

72.8 (13.3)

75.9 (11.9)

74.2 (12.8)

H = 2.7

   

HR

65.7 (9.8)

76.2 (13.5)

73.4 (12.4)

H = 18.3***

 

 < 0.001

0.001

3 min

       

sBP

129.9 (28.6)

126.6 (18.4)

126.0 (15.3)

H = 0.0

   

dBP

89.7 (16.5)

89.2 (15.0)

88.5 (14.9)

H = 1.9

   

HR

74.4 (12.1)

89.7 (17.7)

84.3 (18.1)

H = 20.2***

 

 < 0.001

0.004

5 min

       

sBP

125.6 (23.3)

125.6 (20.2)

122.6 (18.9)

H = 0.5

   

dBP

85.5 (17.8)

89.2 (15.0)

86.0 (13.6)

H = 2.2

   

HR

74.7 (11.7)

91.1 (16.9)

84.6 (17.6)

H = 23.9***

 

 < 0.001

0.004

8 min

       

sBP

124.8 (19.6)

122.0 (24.0)

121.9 (15.2)

H = 0.4

   

dBP

84.4 (15.2)

88.1 (14.7)

84.3 (16.7)

H = 1.7

   

HR

74.7 (10.9)

91.1 (17.4)

85.4 (15.9)

H = 25.2***

 

 < 0.001

 < 0.001

11 min

       

sBP

124.7 (20.7)

121.7 (18.7)

120.7 (19.9)

H = 0.2

   

dBP

83.3 (16.6)

86.5 (15.3)

84.8 (13.7)

H = 1.8

   

HR

75.8 (12.9)

90.5 (16.2)

84.7 (17.9)

H = 19.6***

 

 < 0.001

0.002

Mean values (Tilt)

       

sBP

126.3 (20.8)

128.9 (38.3)

129.4 (43.4)

H = 0.1

   

dBP

85.7 (14.7)

88.5 (13.7)

88.6 (27.4)

H = 0.9

   

HR

74.9 (11.0)

91.6 (17.2)

85.1 (17.0)

H = 26.4***

 

 < 0.001

0.001

  1. For Valsalva maneuver blood pressure data, the differences between the baseline and each phase were taken. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. BRS: baroreflex sensitivity; CO: cardiac output; dBP: diastolic blood pressure; H: Kruskal–Wallis test; HC: healthy controls, HF: high frequency; HR: heart rate; LF: low frequency; ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; nu: normalized units; PRT: pressure recovery time; RRI: R-R interval; sBP: systolic blood pressure; SV: stroke volume; TPR: total peripheral resistance